Leadership

Dr. Edus H. Warren

Edus H. Warren, M.D., Ph.D.

Program Head, Global Oncology

Dr. Edus H. Warren, who assumed leadership of the Global Oncology program in July 2017, is an oncologist specializing in the treatment of patients with blood cancers such as leukemia, lymphoma and multiple myeloma. He is an attending physician at Seattle Cancer Care Alliance, where he serves on the Hematology/Hematologic Malignancy Service.

Warren invests in basic and translational research that will lead to innovative strategies for adapting the advances in cancer research, prevention, diagnosis and treatment made in high-income countries to help address the increasing burden of cancer morbidity and mortality in low- and middle-income countries.

Dr. Thomas Uldrick

Thomas Uldrick, M.D., M.S.

Deputy Head, Global Oncology

Dr. Thomas Uldrick is a hematologist, medical oncologist and clinical investigator whose research focuses on pathogen-associated malignancies, including diseases associated with Kaposi sarcoma herpesvirus and cancer in people with HIV. He conducts early-phase immunotherapy studies and studies that evaluate the immunopathogenesis of cancer in people with HIV. He joined Global Oncology as the deputy head in December 2017.

Uldrick leads efforts to build capacity for clinical and population-based research in the Global Oncology program. The program focuses on high-impact research that advances the science of pathogen-associated malignancies and other globally important cancers that occur in low-resource settings and that leads to innovations with potential to decrease death and suffering from cancer and tumor-causing viruses.

Raquel Sanchez

Raquel Sanchez, M.B.A.

Managing Director, Global Oncology

Raquel Sanchez has spent her 20 year career in cancer research administration. She was named Managing Director of the Global Oncology program at Fred Hutch in July, 2019. Prior to the Hutch, Sanchez spent 13 years at Memorial Sloan Kettering Cancer Center in NY, where she helped build a world-renowned brain cancer program with neurosurgeon/neuroscientist Eric Holland. She was recruited to the Hutch in 2013 to lead its Human Biology Division and support the launch of the Seattle Translational Tumor Research group. After four years she was promoted to associate vice president of Research Administration.

Sanchez’s dedication to building high-performing, inclusive and collaborative teams has garnered her numerous honors, including features in Puget Sound Business Journal’s “Women Who Lead” and the Association of Latino Professionals Women in Leadership (2019), a Puget Sound Business Journal “40 Under 40” award (2017) and a Fred Hutch Administrator of the Year Award (2016). She serves on Fred Hutch’s Diversity Council and the Hutch United Advisory Board, and chairs the board of Education Across Borders, a global health and education foundation.

Dr Warren Phipps

Warren Phipps, M.D., M.P.H.

Medical Director, Uganda Cancer Institute-Fred Hutch Collaboration

Dr. Warren Phipps is an assistant professor at the University of Washington and an assistant member in the Vaccine and Infectious Disease Division at Fred Hutch. Over the past 10 years, he has served as the medical director of the Uganda Cancer Institute-Fred Hutch Collaboration in Kampala, Uganda. He also serves as the director of faculty development for the collaboration and oversees a novel peer mentoring program for early-career investigators in Uganda.

Phipps conducts research on infection-related cancers in sub-Saharan Africa. His research focuses on human herpesvirus-8 virology and the pathogenesis of Kaposi sarcoma. Specific areas of investigation include identifying factors associated with Kaposi sarcoma presentation and treatment outcomes, as well as characterizing host and viral gene expression in Kaposi sarcoma tumors.